Bulletin of Semashko National Research Institute of Public HealthBulletin of Semashko National Research Institute of Public Health2415-84102415-8429FSSBI «N.A. Semashko National Research Institute of Public Health»1661Научная статьяPROACTIVE RISK MANAGEMENT OPPORTUNITIES IN HEALTH CARE BY EXAMPLE OF ONCOLOGICAL PATIENTSMeshkovD. Omeshkovdo@nriph.ruCherkasovS. N-BezmelnitsynaL. Y-IsaevaA. V-National Research Institute for Public Health151220185212914042022Copyright © 2018,2018The effectiveness of medical care, on the example of oncology, is determined mainly by the effectiveness of overcoming the barriers to accessibility of medical technologies (availability, affordability, acceptability, awareness, perception, elimination of administrative barriers). This process takes time, so the only effective way to realize the positive characteristics of medical technology is to plan in advance the volumes of medical care and the conditions that ensure its successful implementation. Proactive risk management in health care takes into account the results of monitoring and forecasting to determine both the need for medical care and availability of medical technology to assess and eliminate the risks associated with public health. The basis for effective monitoring and forecasting of public health is the use of correct statistical information based on a WHO family of international classifications, and the basis for choosing the most effective medical technologies is the forecast (“Horizon Scanning”) of the appearance and evaluation of medical technologies, as well as their optimal use based on clinical recommendations. At present, the main elements of the formation of expert analysis and decision-making mechanism have been created, allowing the use of proactive public health risk management.proactive risk managementorganization of health careinnovative drugsavailabilityclinical guidelinesfamily of international classificationsinternational classification of diseasesoncological diseases1.Хабриев Р.У., Исаева А.В., Безмельницына Л.Ю., Мешков Д.О., Берсенева Е.А., Черкасов С.Н. Доступность инновационных лекарственных препаратов и снижение показателей смертности от онкологических заболеваний. Бюллетень Национального научно-исследовательского института общественного здоровья, 2016. № 5, стр.5-19.2.Brian Godman, Rickard E Malmstrom, Eduardo Diogene, Andy Gray, e.a. Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? Expert Rev. Clin. Pharmacol. 8(1), 77-94 (2015).3.Sergey Cherkasov, Dmitry Meshkov, Alexander Shoshmin, Yanina Besstrashnova, Evgeniya Berseneva, Ludmila Bezmelnitsyna, Anna Fedyaeva, Valeria Oleinikova. WHO-FIC Network Annual Meeting 16-21 October 2017. New challenges for spreading and support of WHO classifications. C.704.4.Черкасов С.Н., Мешков Д.О., Берсенева Е.А., Федяева А.В., Олейникова В.С., Кучук С.А., Максимов А.В. Семейство международных классификаций на современном этапе развития Российского здравоохранения / Судебная медицина. 2018. Т.4. №3. С.43-46.5.EuroScan International Network [Электронный ресурс]. URL: https://www.euroscan.org (дата обращения 3.12.2018).6.Trends, Charts, and Maps [Электронный ресурс]: Database ClinicalTrials.gov. URL: https://clinicaltrials.gov/ct2/resources/trends (дата обращения 3.12.2018).7.Cochrane Database of Systematic Reviews (CDSR) [Электронный ресурс]: Cochrane library. URL: https://www.cochranelibrary.com/cdsr/reviews (дата обращения 4.12.2018).8.Guidelines International Network [Электронный ресурс]. URL: www.g-i-n.net (дата обращения 6.12.2018).9.Бубнова М.Г, Бутурина Е.К., Выгодин В.А., Колтунов И.Е. и др. Основы доказательной медицины. Учебное пособие. Москва 2010. УДК 616 (075.8).10.WHO handbook for guideline development [Электронный ресурс]: World Health Organization. URL: http://apps.who.int/iris/bitstream/10665/75146/1/ 9789241548441_eng.pdf (дата обращения 6.12.2018).